Answers are grounded in this paper and cite their sources.
This study in a nationwide mass vaccination setting suggests that the BNT162b2 mRNA vaccine is effective for a wide range of Covid-19-related outcomes, a finding consistent with that of the randomized trial.
No takes yet. Share an insight, caveat, or question.
Dagan et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: